3 Biotech Stocks to Sell in August Before They Crash & Burn

For investors, one of the most attractive aspects of biotech stocks is their ability to increase in value in a short period of time quickly. After all, it only takes one major breakthrough in clinical trials or a Food and Drug Administration approval to rush a stock into the headlines rapidly. Yet, as quickly as these securities go up, so too can they come down, resulting in biotech stocks to sell. In these cases, investors who act quickly or see through the hype can avoid portfolio losses while maximizing ...